Characteristics, treatment and outcomes of HER2 positive male breast cancer

Research describing male breast cancer with HER2 overexpression is limited. This study evaluated the characteristics, treatment, and outcomes of HER2 positive breast cancer in men. Information for January 2010 through December 2017 was obtained from the SEER Research Plus database. Four hundred sixt...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of surgery 2023-03, Vol.225 (3), p.489-493
Hauptverfasser:	Esposito, Adrienne, Ablah, Elizabeth, Okut, Hayrettin, Tenofsky, Patty L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast cancer Breast Neoplasms - pathology Breast Neoplasms, Male - therapy Cancer surgery Cancer therapies Chemotherapy Diagnosis ErbB-2 protein HER2 Human epidermal growth factor receptor 2 Humans Lymph nodes Lymphatic system Male Male breast cancer Males Medical prognosis Men Mens health Metastasis Receptor, ErbB-2 Treatment Outcome Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Research describing male breast cancer with HER2 overexpression is limited. This study evaluated the characteristics, treatment, and outcomes of HER2 positive breast cancer in men. Information for January 2010 through December 2017 was obtained from the SEER Research Plus database. Four hundred sixty-two men were HER2 positive (13%) of 3594 cases of breast cancer. Compared to HER2 negative patients, these patients were younger at diagnosis (63 vs. 67 years, p
ISSN:	0002-9610 1879-1883
DOI:	10.1016/j.amjsurg.2022.12.009